CommercialAdministrativeLow impact
HEDIS Antidepressant Medication Management (AMM)
Blue Cross Blue Shield of Rhode Island·RI · Psychiatry, Family Medicine, Internal Medicine·Behavioral Health
Effective date
Aug 1, 2022
We identified it
Jun 19, 2026
Summary
HEDIS Antidepressant Medication Management (AMM) policy establishes quality measures for members 18+ with major depression who are treated with antidepressant medications. The measure tracks two phases: effective acute phase and effective continuation phase treatment compliance.
Action Required
Review HEDIS AMM quality measure requirements for members 18+ with major depression on antidepressant medications. Ensure proper documentation supports both acute phase and continuation phase treatment tracking for quality reporting purposes.